货品编号： abcam.ab272938

品牌： abcam

品名： Recombinant Anti-CCR7 antibody [EPR23192-57] - BSA and Azide free

规格： 100ug

• Product nameAnti-CCR7 antibody [EPR23192-57] - BSA and Azide freeSee all CCR7 primary antibodies
• DescriptionRabbit monoclonal [EPR23192-57] to CCR7 - BSA and Azide free
• Host speciesRabbit
• Tested applicationsSuitable for:IHC-Fr,IHC-Pmore detailsUnsuitable for:Flow Cyt,IP or WB
• Species reactivityReacts with:Mouse, Rat, Human
• Immunogen

  Synthetic peptide. This information is proprietary to Abcam and/or its suppliers.

• Positive control
  • IHC-P: Human tonsil, Human Hodgkin's lymphoma, Mouse spleen and Rat spleen tissues. IHC-Fr: Mouse spleen and Rat spleen tissues.
• General notes

  ab272938 is the carrier-free version ofab253187.

  Ourcarrier-freeantibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. The carrier-free buffer and high concentration allow for increased conjugation efficiency.

  This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.

  Use ourconjugation kitsfor antibody conjugates that are ready-to-use in as little as 20 minutes with <1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.

  This product is compatible with the Maxpar®Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar®is a trademark of Fluidigm Canada Inc.

  This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free production

  For more informationsee here.

  Our RabMAb®technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer toRabMAb®patents.